Annexin IV Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-60359m-100uL |
| Product Name | Annexin IV Recombinant Antibody |
| Applications |
WB
IHC-P
IHC-F
IF
ICC/IF
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Mouse |
| Source | KLH conjugated synthetic peptide derived from human Annexin IV |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot Dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 307 |
| Swiss Prot | P09525 |
| Subcellular location | Secreted |
| Synonyms | 35 beta calcimedin; Carbohydrate binding protein P33/P41; DKFZp686H02120; Endonexin I; Lipocortin IV; P32.5; Annexin A4; Annexin IV placental anticoagulant protein II; ANX 4; ANX A4; ANX4; ANXA 4; LipocortinIV; P33/41; Placental anticoagulant protein II antibody PP4X; Proliferation inducing protein 28; ANXA4_HUMAN. |
| Background | The Annexins are a family of structurally similar proteins. Annexins bind to phospholipids and may be involved in regulation of membrane transport, membrane channel activity, and interaction of the cell membrane with the extracellular matrix. Annexin A4 (ANXA4) belongs to the annexin family of calcium dependent phospholipid binding proteins. Although their functions are still not clearly defined, several members of the annexin family have been implicated in membrane related events along exocytotic and endocytotic pathways. ANXA4 has 45 to 59% identity with other members of its family and shares a similar size and exon intron organization. Isolated from human placenta, ANXA4 encodes a protein that has possible interactions with ATP, and has in vitro anticoagulant activity and also inhibits phospholipase A2 activity. ANXA4 is almost exclusively expressed in epithelial cells. |
| Application Dilution | |
| WB | =1:200-1000 |
| IHC-P | IHC-P=1:50-100 |
| IHC-F | ICC=1:50 |
| IF | IF=1:50 |
| ICC/IF | 1:50-100 |
Frequently asked questions
Which applications is Annexin IV Recombinant Antibody (bsm-60359M) validated for, and at what dilution?
bsm-60359M is validated for WB (WB=1:200-1000); IHC-P (IHC-P=1:50-100); IHC-F (ICC=1:50); IF (IF=1:50); ICC/IF (1:50-100). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does Annexin IV Recombinant Antibody (bsm-60359M) react with?
Tested reactivity: Human.
How should bsm-60359M be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
What immunogen was used to raise Annexin IV Recombinant Antibody (bsm-60359M)?
KLH conjugated synthetic peptide derived from human Annexin IV